Skip to Content

M C1 (Captopril 12.5 mg)

Pill with imprint M C1 is White, Elliptical / Oval and has been identified as Captopril 12.5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Captopril is used in the treatment of high blood pressure; heart failure; hypertensive emergency; diabetic kidney disease; cystinuria (and more), and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Captopril 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M C1

Captopril 12.5 mg M C1
Captopril 12.5 mg M C1  Front
Captopril 12.5 mg M C1  Back
Captopril 12.5 mg M C1


M C1
12.5 mg
8.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
lactose anhydrous
silicon dioxide
microcrystalline cellulose
stearic acid
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0863 UDL Laboratories Inc.
43063-0146 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.